Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Congress 2023
  5. Exhibition
  6. Exhibitors

ESMO Congress 2023: Companies

ESMO-Congress-2023-Banner-1000x250px

AbbVie

SL-Abbvie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

Accord Healthcare

SL-Accord

Headquartered in the United Kingdom, Accord Healthcare is a fast-growing global pharmaceutical company that develops, manufactures and distributes medicines in over 85 countries worldwide, helping to improve access for patients to pharmaceutical care.

Actualway Medical Devices

SL-Actualway

We are a Portuguese manufacturer of Therapy Chairs, Sampling, Blood Donation Chairs and Multifunctional Chairs for several medical specialties. We have distributers in 49 countries worldwide. Actualway is certificated with ISO9001 and ISO13485.

Agilent

SL-Agilent

Agilent provides laboratories with solutions enabling them to gain the insights they seek. With the extensive cancer diagnostic know-how, our business has established partnerships with clinical labs specializing in pathology and genetic testing.

Alkermes

SL-Alkermes-Logo

Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company is based in Dublin, Ireland.

Almac Group

SL-Almac

Your global partner for biomarker discovery, development and commercialisation. Our global CLIA and CAP accredited laboratories cover UK, Europe, USA & APAC regions. Our cores services include Genomic Services, Clinical Trial Assays and CDx.

Amgen

SL-Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics.

Amoy Diagnostics Co., Ltd.

SL-Amoy-Diagnostics-Chinese

Amoy Diagnostics Co., Ltd. is a pioneer and globally leading company in the field of molecular diagnostics for precision oncology, focusing on companion diagnostics product development and commercialization.

Arcus Biosciences

SL-Arcus

Arcus Biosciences is a clinical-stage, global biopharmaceutical company with six investigational medicines in clinical studies, including new combination approaches that target TIGIT, PD-1, CD73, dual A2a/A2b and HIF-2a.

Arvinas, Inc.

SL-Arvinas

Arvinas is a clinical-stage biotech company dedicated to improving the lives of patients by developing PROTAC® protein degraders designed to harness the body’s natural protein disposal system to degrade disease-causing proteins. 

Virtual-Exhibition-Icon

Ascendis Pharma

SL-AACR

Guided by its core values of patients, science and passion, Ascendis Pharma uses its TransCon technologies to create new and potentially best-in-class therapies.

Astellas Pharma Inc.

SL-Astellas

Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients.

AstraZeneca

SL-AstraZeneca

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

Axiom Healthcare Strategies

SL-Axiom

Axiom Healthcare Strategies is a collaborative, life-sciences think tank that focuses on oncology and rare diseases. Axiom works together with industry and clinical leaders to provide cutting edge thought leadership to its clients.

Bayer

SL-Bayer

Bayer is committed to SCIENCE FOR A BETTER LIFE by advancing innovative treatments. The oncology franchise reflects the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.

BEACON Medicare Limited 

Beacon is one of the fastest growing Pharma company & No.1 Oncology company in Bangladesh. The International Quality Standard products of Beacon are manufactured in GMP compliant facilities. Patients of 135 countries are now using Beacon’s Medicines.

SL-Beacon-Medicare

BeiGene

SL-Beigene

BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide.

Biocartis NV

Biocartis is an innovative MDx company with a focus on oncology. It aspires to enable personalized medicine for patients around the world through universal access to molecular testing, by making it convenient, fast and suitable for any lab.

SL-Biocartis

Biome Diagnostics

SL-Biome-Diagnostics

BiomeDx is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care.

Boehringer Ingelheim International GmbH

SL-Boehringer-Ingelheim-blue

For Boehringer Ingelheim, cancer care is personal, today and for generations.

BostonGene

SL-Boston-Gene

BostonGene’s mission is to power healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and reduce overall cost of cancer care.

Bristol Myers Squibb

SL-Bristol-Myers-Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Burning Rock Dx LLC

SL-Burning-Rock

Burning Rock Dx (NASDAQ: BNR) is committed to providing NGS-based testing for cancer patients, biomarker detection and companion diagnostic development services to pharmaceutical partners, and NGS-based multi-cancer early detection testing.

C2i Genomics

Sl-C2i

C2i Genomics cloud-based platform offers ultra-sensitive whole-genome sequencing cancer detection and monitoring with low input blood and streamlined lab workflow for genomic labs across the globe, supporting more personalized treatment management.

Caris Life Sciences

SL-Caris

Caris Life Sciences® is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes.

CATALYSIS, S. L.

SL-Catalysis

Catalysis manufactures quality products using exclusive molecular technology. Our focus in the Oncological field enhances quality of life during aggressive therapies. Ocoxin, with green tea and Cinnamon extract, has 20+ cancer-related publications.

CeGaT

SL-CeGat

CeGaT, founded in 2009 in Tübingen, Germany, is a global provider of genetic diagnostics and sequencing services. CeGaT’s laboratory is accredited according to CAP/CLIA, DIN EN ISO 15189, and DIN EN ISO/IEC 17025.

ChemoMouthpiece, LLC

SL-Chemo

ChemoMouthpiece is an oncology supportive care company. Our device, the Chemo Mouthpiece™ is an intraoral icepack designed to deliver cryotherapy to the oral cavity of patients receiving chemotherapy. It proactively manages and treats oral mucositis.

Clario

SL-Clario

Clario is a leader in healthcare research & technology, generating the richest clinical evidence in the industry. Our deep scientific expertise, global scale and the broadest endpoint technology platform allows our partners to transform lives.

COR2ED

SL-Cor2ed

COR2ED develops independent medical programmes with leading experts & medical societies, bridging science to clinical practice. Programmes support our community of half-a-million healthcare professionals to care for patients.

Daiichi Sankyo

SL-Daiichi-Sankyo

With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an Innovative Global Health.

Datar Cancer Genetics

SL-Datar-Cancer-Genetics

Datar Cancer Genetics is an international diagnostic company offering advanced solutions in oncology to personalise treatment as well as early cancer detection. The company’s main focus is on liquid biopsies but provides also highend tissue analyses.

Deciphera Pharmaceuticals AG

Deciphera is focused on discovering, developing, and commercializing new medicines to improve the lives of people with cancer. Leveraging our proprietary switch-control kinase inhibitor platform, we are advancing candidates into clinical studies.

SL-Deciphera-Pharmaceuticals

Devyser

SL-Devyser

Devyser develops, produces, and sells genetic testing kits and services to clinical laboratories globally. Our products are used for advanced DNA testing for hereditary cancer and in oncology to enable targeted cancer treatment.

Diagnóstica Longwood

SL-Diagnostica-Longwood

Diagnóstica Longwood was founded 30 years ago with the aim of satisfying the needs of the laboratory professional, over the years specialising in molecular diagnostic and offering our clients an integrated, personalised and efficient service.

Eisai

SL-Eisai

At Eisai, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy.

Elekta

SL-Elekta

Elekta advances outcome-driven solutions that bring hope to everyone dealing with cancer. Our digital therapeutics platform, Kaiku Health, triages symptoms, notifies care teams and provides patients with personalized support.

Elevar Therapeutics

SL-Elevar

Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options.

Eli Lilly and Company

SL-Lilly

Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years. Today our medicines help more than 47 million people across the globe.

Entrogen

SL-Entrogen

We offer end-to-end solutions in molecular diagnostics for oncology and hematology providing hardware,reagents and software.Starting from automated nucleic acid extraction to genomic interpretation with our software embedded for key decision support.

Ercules

SL-Ercules

At Ercules, with our well-established expertise in patient education, we support pharma, device companies and CROs with solutions for international clinical trial recruitment/retention and treatment compliance in adult and pediatric populations.

Exact Sciences

SL-ExactSciences

Exact Sciences is a leader in cancer testing. From earlier cancer detection to treatment guidance and therapy selection, the company’s portfolio of tests and pipeline are intended to support patients before, during and after diagnosis.

Exelixis

SL-Exelixis

Exelixis is an oncology-focused biotechnology company striving to accelerate discovery, development, and commercialization of products for difficult-to-treat cancers through continued evaluation of approved products and expansion of product pipeline.

Fortrea

SL-Fortrea

Fortrea is now the brand identity for Labcorp's Clinical Development business. Fortrea is a provider of phase I-IV clinical trial management, regulatory guidance, patient access solutions and market access consulting.

Genmab

SL-Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics.

Gilead and Kite Oncology

SL-Gilead-Kite

Gilead and Kite Oncology are creating the future of oncology. From ADCs and small molecules to cell therapy, our R&D programs and partnerships are focused on helping to bring more life to people with cancer and changing the way cancer is treated.

Virtual-Exhibition-Icon

GSK

SL-GSK

GSK is enhancing patient survival through transformational medicines: immuno-oncology, tumor cell targeting & synthetic lethality therapies. We are also developing innovative vaccines that may help protect cancer patients against infectious diseases.

Virtual-Exhibition-Icon

Guardant Health, Inc 

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.

SL-Guardant

Haystack Oncology

SL-Haystack

We use the next generation of ctDNA detection technology to see through the noise and uncover the lowest ctDNA levels in blood to report residual, recurrent, or resistant disease earlier than any other MRD test.

Helsinn Healthcare SA

SL-Helsinn

Helsinn, a fully integrated global biopharma company with a leading position in cancer supportive care and focus in oncology and rare diseases, is the partner of choice for the biotech and pharma sector.

Virtual-Exhibition-Icon

ID SOLUTIONS Oncology

SL-ID-Solutions

ID SOLUTIONS Oncology is a French company specialized in the in vitro diagnostic medical devices dedicated to oncology. We develop, produce and market complete solutions, from DNA extraction to molecular typing, using multiplexed digital PCR kits.

Illumina

SL-Illumina-black

At Illumina, our mission is to improve human health by unlocking the power of the genome. Our comprehensive genomic profiling tools help investigators identify biomarkers, describe tumor biology, and inform therapy selections.

Immunocore

SL-Immunocore

Immunocore launched the world’s first TCR therapy in 2022, on a mission to radically improve outcomes for patients living with cancer, infectious diseases, and autoimmune conditions by pioneering and delivering transformative medicines.

Virtual-Exhibition-Icon

Incyte

SL-Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.

Indivumed Therapeutics

SL-Indivumed

Valued for standardized collection and analysis of biospecimen, our unique multi-omics database unlocks the molecular reality of cancer, supporting biomarker & therapeutic target discovery and validation, drug development, and clinical validation.

Institut Curie

SL-Institute-Curie

Institut Curie is a world leading comprehensive cancer center and a basic research center, located in Paris , combines an internationally-renowned research center with a cutting-edge hospital group that treats all types of cancer.

Ipsen

SL-Ipsen

Ipsen is a global biopharmaceutical company focused on transformative medicines in Oncology, Neuroscience and Rare Diseases.

Job Code: ALLSC-ALL-001727
Date of Preparation May 2023

Virtual-Exhibition-Icon

IQVIA Biotech

SL-IQVIA-Biotech

IQVIA Biotech delivers flexible clinical development solutions to help biotech companies get treatments to patients. Our dedicated oncology team brings expertise from two decades of delivering clinical trials exclusively for biotech companies.

Janssen Oncology

SL-Janssen

At Janssen Oncology, our purpose is to make cancer a manageable and, ultimately, curable condition. The power to change the lives of those living with cancer begins with a very considered step forwards. That’s The Power of Purpose™.

Liberum Independent Medical Education

SL-Liberum

Liberum IME creates innovative programs that provide targeted evidence-based education to healthcare professionals who are seeking to grow their knowledge and improve patient care.

LIDE Biotech

SL-Lide

LIDE is an AALAC accredited contract research organization for oncology. We offer traditional CRO services in pharmacology, but also have CR (conditionally reprogrammed) cell lines and 1800+ PDX mouse models derived directly from our patient network.

Med Learning Group

Our immersive 3D Virtual Reality Room experience will allow clinicians to be exposed to current perspectives on first-line therapeutic options informing the use of immunotherapy in advanced NSCLC.

SL-Med-Learning

MEDEXPRIM

SL-Medexprim

European leader in imaging & clinical data extraction. Creating multimodal Real-World datasets for oncology, cardiology & rare diseases. Our goal: Structuring the EU Real-World clinical & imaging data ecosystem to accelerate precision medicine.

Median Technologies

SL-Median

Median Technologies turns medical images into powerful clinical insights using AI. With iCRO, we provide imaging services for oncology trials. With iBiopsy, we deploy AI/ML tech based SaMD, to help healthcare professionals diagnose cancers early.

Medicover Genetics

SL-Medicover-Genetics

Medicover Genetics is a leading healthcare company offering an extensive portfolio of genetic testing services including hereditary, tumor profile and liquid biopsy, a versatile Technology Transfer Platform, and proprietary CE IVD marked solutions.

Medscape Oncology

SL-Medscape

Medscape Oncology is the leading online destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives as well as continuing medical education in a variety of engaging formats.

Merck Healthcare KGaA

SL-Merck-blue

We are committed to improving the futures of those living with cancer. By maximizing the impact of our standard-of-care treatments and pioneering new medicines, we endeavor to create a world where more cancer patients can become cancer survivors.

MERIT CRO, Inc.

SL-Merit

MERIT is a global clinical trial endpoint services provider offering reliable and attentive expertise in our therapeutic areas.

Mersana Therapeutics

SL-Mersana

Mersana Therapeutics is a biotech company using its differentiated & proprietary ADC platforms to develop novel ADCs like investigational candidates UpRi, XMT-1660, and other ADCs, leveraging Dolaflexin, Dolasynthen and Immunosynthen platforms.

Mirati Therapeutics

Mirati Therapeutics is a biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones.

SL-Mirati-Therapeutics

Moderna

Founded in 2010, Moderna is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines.

SL-Moderna

MSD

SL-MSD

At MSD, our goal is to translate breakthrough science into innovative oncology medicines. As part of our focus on cancer, MSD is committed to clinical research with one of the largest development programs in the industry.

Virtual-Exhibition-Icon

Myriad Genetics

Myriad Genetics is a genetic testing and precision medicine company dedicated to advancing health and well-being for all. In Europe, Myriad offers genetic tests through local testing collaborations that can help personalize and improve cancer care.

SL-Myriad

Nanolive

SL-Nanolive

Nanolive offers label-free phenotypic screening analysis solutions de-risking drug discovery and cell therapy. The technology measures living cells, at sub-cellular resolution (e.g. lipid droplets or mitochondria) for higher translational relevance.

Natera

SL-Natera

Natera is a global leader in cell-free DNA testing. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.

NeoGenomics

SL-NeoGenomics

NeoGenomics, Inc. specializes in cancer genetics testing and information services to help physicians diagnose and treat cancer. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development.

Novartis

SL-Novartis

Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Virtual-Exhibition-Icon

Novocure GmbH

SL-Novocure

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields).

Novogene Europe

SL-Novogene

Novogene utilises its large sequencing capacity, deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their NGS research goals. In this conference, we will exhibit the latest genome sequencing solutions.

OCT Clinical

SL-OCT-Clinical

OCT Clinical is a full-service clinical CRO with strong local expertise and focus on quality. Since 2005, OCT team has conducted over 360 clinical trials (Phase I-IV and BE) in Eastern and Central Europe in multiple therapeutic areas.

OncLive®

SL-Onclive

OncLive® is the most comprehensive multimedia resource for the global oncology community. We combine objective facts and expert insights to help educate and inform health care providers so they can deliver the best possible patient care.

ONCOassist

SL-Oncoassist-white

ONCOassist® is the free, CE-approved, go-to, decision support app for oncology professionals. It gives them instant access to relevant, up-to-date oncology-specific tools and content.
It has over 70K users in more than 150 countries.

OncoDNA

SL-OncoDNA

OncoDNA Group offers a unique portfolio that combines NGS services, biomarker testing and data analysis software. Our diagnostic tests support oncologists, labs, research institutes and biopharmaceutical companies around the world.

Oncompass

SL-Oncompas

Oncompass offers a complex, AI-driven precision oncology program that includes all steps from diagnostics to providing patients with a therapy plan that's tailored to their tumor's unique genetic makeup for better patient outcomes.

OSE Immunotherapeutics

SL-OSE-Immunotherapeutics

OSE Immunotherapeutics is a clinical-stage biotech in immuno-oncology & immuno-inflammation: R&D platforms based on T lymphocyte cell and myeloid cell immunity and development of first-in-class products directly or via partnerships with the pharma.

Owkin

SL-Owkin

Owkin is an AI biotechnology company on a mission to find the right treatment for every patient. By understanding complex biology through AI, we identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools.

Parexel

SL-Parexel

As a leading global CRO, Parexel supports the development of innovative new medicines to improve the health of patients. We provide services to help life sciences and biopharmaceutical clients transform scientific discoveries into new treatments.

Paxman Scalp Cooling

SL-Paxman

Paxman are global leaders in scalp cooling, which is clinically proven to help to manage chemotherapy-induced hair loss and promote faster hair regrowth. Go to paxmanscalpcooling.com for clinical data and system information.

Pear BIO

SL-Pear-Bio

Pear Bio is a London-based computational biology company discovering predictive biomarkers to guide cancer treatment for improved patient outcomes through multivariate analyses of 3D immuno-oncology cell cultures. 

Personalis, Inc.

SL-Personalis

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. Our assays combine tumor-and-normal profiling with proprietary algorithms to deliver the most advanced insights, even as cancer evolves.

Pfizer Oncology

SL-Pfizer-Oncology

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Visit Pfizer.com to learn more.

PharmaMar

SL-PharmaMar

PharmaMar is a biopharmaceutical company inspired by the sea, driven by science and motivated by patients with serious diseases to improve their lives by delivering novel medicines. PharmaMar commercializes Yondelis in EU and Zepzelca in Switzerland.

Pierre Fabre Group

SL-Pierre-Fabre

Pierre Fabre is a French company that dedicated 80% of its R&D spendings to oncology in 2022 and set targeted therapies as its R&D priority. Its portfolio covers colorectal, breast and lung cancers, melanoma, hematology, pre-cancerous skin conditions.

Pillar Biosciences

SL-Pillar

Pillar Biosciences provides kitted NGS solutions to support solid tumor, blood tumor and liquid biopsy testing based on our SLIMamp technology, which empowers all NGS labs with a simple, scalable, single-day workflow enabling faster clinical results.

PIVOTAL

SL-Pivotal

Pivotal was born in 2001 surrounded by an environment of high scientific tenure and drive, on the principle that strategic scientific-medical advice and support should be the backbone of all clinical trials.

PPD, part of Thermo Fisher Scientific

SL-PPD

PPD clinical development and analytical services enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas.

Precision for Medicine

SL-Precision-for-medicine-logo

Navigate your pathway to approval with Precision for Medicine’s deep oncology expertise and end-to-end capabilities—Global CRO, Central and Specialty Labs, Data Sciences, Manufacturing, Biospecimens, Commercialization. Together we can realize more.

Predicine

SL-Predicine

Predicine is a molecular insights company that is developing cfDNA- and cfRNA-based liquid biopsy technologies to enable minimally invasive molecular diagnosis for early cancer detection, treatment selection, and minimal residual disease monitoring.

Premier Research

SL-Premier-Research

Premier Research, a clinical research company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.

ProPharma

SL-Propharma

For 20+ years, ProPharma has improved the health & wellness of patients by providing advice & expertise empowering biotech, med device, and pharmaceutical organizations to confidently advance scientific breakthroughs & introduce new therapies.

Quibim

SL-Quibim

Quibim is dedicated to designing innovative tools that unlock imaging data to enhance patient outcomes. Our core focus is the application of AI to medical imaging to unclose previously inaccessible data and convert it into actionable insights.

Radiomics

SL-Radiomics

Imaging & AI research organisation, Radiomics, supports pharma & biotech companies in clinical development to extract the maximum information from clinical trial images in oncology & other areas through Radiomics, Deep Learning & Federated Learning.

Regeneron

SL-Regeneron

Regeneron is a biotechnology company that develops medicines for serious diseases. Founded by physician-scientists, our ability to translate science into medicine has led to numerous FDA-approved treatments and investigational candidates.

Replimune

SL-Replimune

Replimune is pioneering a new class of tumor directed oncolytic immunotherapies (TDOI) designed to ignite a powerful patient-specific immune response to treat cancer and vaccinate against future relapse.

RESILIENCE

SL-Resilience

Resilience is a Remote Patient Care solution dedicated to cancer patients and caregivers. Through a mobile application and a Remote Patient Monitoring platform, Resilience combines two products into a comprehensive solution to ensure a better care.

Roche

SL-Roche

Roche is a pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, hematology and beyond.

RS ONCOLOGY

SL-RS-Oncology

RS Oncology is working swiftly to bring its groundbreaking science and innovative treatment options to patients with unmet medical needs, specifically mesothelioma and malignant pleural effusion.

Sanofi

SL-Sanofi

At Sanofi, we recognize the burden that cancer places on patients and caregivers. Our aspiration is to drive the evolution of the treatment of cancer, transform patient care, and impact the lives of people living with many different types of cancer.

Seagen

SL-Seagen

Seagen discovers, develops, manufactures, and commercializes targeted cancer therapeutics.

Servier

SL-Servier

Founded to serve health, Servier aspires to have a social impact for patients and has made oncology and in particular hard-to-treat cancers a priority focus, with 19 projects in clinical development in both targeted therapies and immuno-oncology.

Springer Healthcare

SL-Springer-Healthcare

Springer Healthcare’s expert-led medical educational programs are designed to bring about meaningful and measurable change in physician behavior, increasing diagnostic ability, optimizing treatment regimens, and ultimately improving patient outcomes.

Stemline. A Menarini Group Company

Stemline. a Menarini Group Company is committed to making difference in cancer patients’ lives. We invest in developing precision medicine through our pipeline of investigational drugs. Partnering with cancer experts and research institutions globall

SL-Menarini-Stemline-Horizontal

Syneos Health

SL-Syneos-Health

Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.

Sysmex Europe SE

SL-Sysmex

Sysmex is continuously striving to create a better healthcare journey for all. In the field of life science, we have an ever-growing portfolio of solutions used throughout the pathway of cancer care in prevention, detection, diagnosis, and treatment.

Taiho Oncology, Inc.

SL-Taiho-Oncology

Taiho Oncology Europe GmbH specializes in orally administered anti-cancer agents and has a growing pipeline of selectively targeted anti-cancer agents. It is the European subsidiary of Taiho Pharmaceutical Co., Ltd.

Virtual-Exhibition-Icon

Takara Bio Europe

SL-Takara

Takara Bio Europe, a subsidiary of Takara Bio Inc., offer a wide range of life science reagents. Their portfolio supports applications including NGS, cloning, genetic analysis, protein expression and purification, gene editing and stem cell research.

Takeda

SL-Takeda

At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere.

Tempus

SL-Tempus

AI-enabled precision medicine Bringing the power of data and artificial intelligence to healthcare.

Tigermed

SL-Tigermed

Tigermed is devoted to building an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challenges to fulfill our commitment to serving unmet patients’ needs, and ultimately saving lives.

Varian, a Siemens Healthineers company

SL-Varian

Varian, a Siemens Healthineers company, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy.

Voiant

SL-WorldCare-Clinical

MedQIA, WorldCare Clinical, and DARC unite as VoiantSM, the new leader in clinical trial imaging endpoint data. Voiant’s leading experts, advanced technology, and operational excellence ensure the highest quality imaging data for your trial.

Worldwide Clinical Trials

SL-World-Clinical-Trials

Worldwide Clinical Trials is a global, midsize CRO that provides top-performing bioanalytical and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries.

Presence on the Virtual Congress Platform

Virtual-Booth-1000x1000

Note: Exhibitor profiles including the icon above, will be present in the ESMO Congress 2023 Virtual Exhibition.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.